Setting Ranges in Potential Biomarkers for Type 2 Diabetes Mellitus Patients Early Detection By Sex-An Approach with Machine Learning Algorithms.

Type 2 diabetes mellitus (T2DM) is one of the most common metabolic diseases in the world and poses a significant public health challenge. Early detection and management of this metabolic disorder is crucial to prevent complications and improve outcomes. This paper aims to find core differences in male and female markers to detect T2DM by their clinic and anthropometric features, seeking out ranges in potential biomarkers identified to provide useful information as a pre-diagnostic tool whie excluding glucose-related biomarkers using machine learning (ML) models. We used a dataset containing clinical and anthropometric variables from patients diagnosed with T2DM and patients without TD2M as control. We applied feature selection with three different techniques to identify relevant biomarker models: an improved recursive feature elimination (RFE) evaluating each set from all the features to one feature with the Akaike information criterion (AIC) to find optimal outputs; Least Absolute Shrinkage and Selection Operator (LASSO) with glmnet; and Genetic Algorithms (GA) with GALGO and forward selection (FS) applied to GALGO output. We then used these for comparison with the AIC to measure the performance of each technique and collect the optimal set of global features. Then, an implementation and comparison of five different ML models was carried out to identify the most accurate and interpretable one, considering the following models: logistic regression (LR), artificial neural network (ANN), support vector machine (SVM), k-nearest neighbors (KNN), and nearest centroid (Nearcent). The models were then combined in an ensemble to provide a more robust approximation. The results showed that potential biomarkers such as systolic blood pressure (SBP) and triglycerides are together significantly associated with T2DM. This approach also identified triglycerides, cholesterol, and diastolic blood pressure as biomarkers with differences between male and female actors that have not been previously reported in the literature. The most accurate ML model was selection with RFE and random forest (RF) as the estimator improved with the AIC, which achieved an accuracy of 0.8820. In conclusion, this study demonstrates the potential of ML models in identifying potential biomarkers for early detection of T2DM, excluding glucose-related biomarkers as well as differences between male and female anthropometric and clinic profiles. These findings may help to improve early detection and management of the T2DM by accounting for differences between male and female subjects in terms of anthropometric and clinic profiles, potentially reducing healthcare costs and improving personalized patient attention. Further research is needed to validate these potential biomarkers ranges in other populations and clinical settings.

Feature Selection of Motor Activity in Intervals of Time with Genetics Algorithms for Depression Detection / Selección de Características de la Actividad Motora en Intervalos de Tiempo con Algoritmos Genéticos para la Detección de Depresión

Abstract It is estimated that depression affects more than 300 million people in worldwide. Unfortunately, the current method of psychiatric evaluation requires a great effort on the part of clinicians to collect complete information. The aim of this paper is determine the optimal time intervals to detect depression using genetic algorithms and machine learning techniques; from motor activity readings of 55 participants during a week at one-minute intervals. The time intervals with the best performance in detecting depression in individuals were selected by applying Genetic Algorithms (GA). Methodology. 385 observations of the study participants were evaluated, obtaining an accuracy of 83.0 % with Logistic Regression (LR). Conclusion. There is a relationship between motor activity and people with depression since it is possible to detect it using machine learning techniques. However, the changes in the variables of the time intervals could be established as key factors since, at different times, they could give good or bad results because the motor activity in the patients could vary. However, the results present a first approximation for developing tools that help the opportune and objective diagnosis of depression.

Resumen Se estima que la depresión afecta a más de 300 millones de personas en el mundo. Desafortunadamente, el método de evaluación psiquiátrica actual requiere un gran esfuerzo por parte de los médicos para recopilar información completa. Objetivo. Determinar los intervalos de tiempo óptimos para detectar depresión mediante algoritmos genéticos y técnicas de aprendizaje automático, a partir de las lecturas de actividad motora de 55 sujetos durante una semana en intervalos de un minuto. Los intervalos de tiempo con mejor desempeño en la detección de depresión en individuos fueron seleccionados aplicando algoritmos genéticos. Metodología. Se evaluaron 385 observaciones de los sujetos de estudio, obteniendo una precisión del 83.0 % con Regresión Logística (LR). Conclusión. Existe una relación entre la actividad motora y las personas con depresión ya que es posible detectarla utilizando técnicas de aprendizaje automático. Sin embargo, los cambios en las variables de los intervalos de tiempo podrían establecerse como factores clave ya que en diferentes momentos podrían dar buenos o malos resultados debido a que la actividad motora en los pacientes podría llegar a variar. No obstante, los resultados presentan una primera aproximación para el desarrollo de herramientas que ayuden al diagnóstico oportuno y objetivo de la depresión.

Metabolomic Selection in the Progression of Type 2 Diabetes Mellitus: A Genetic Algorithm Approach.

According to the World Health Organization (WHO), type 2 diabetes mellitus (T2DM) is a result of the inefficient use of insulin by the body. More than 95% of people with diabetes have T2DM, which is largely due to excess weight and physical inactivity. This study proposes an intelligent feature selection of metabolites related to different stages of diabetes, with the use of genetic algorithms (GA) and the implementation of support vector machines (SVMs), K-Nearest Neighbors (KNNs) and Nearest Centroid (NEARCENT) and with a dataset obtained from the Instituto Mexicano del Seguro Social with the protocol name of the following: "Análisis metabolómico y transcriptómico diferencial en orina y suero de pacientes pre diabéticos, diabéticos y con nefropatía diabética para identificar potenciales biomarcadores pronósticos de daño renal" (differential metabolomic and transcriptomic analyses in the urine and serum of pre-diabetic, diabetic and diabetic nephropathy patients to identify potential prognostic biomarkers of kidney damage). In order to analyze which machine learning (ML) model is the most optimal for classifying patients with some stage of T2DM, the novelty of this work is to provide a genetic algorithm approach that detects significant metabolites in each stage of progression. More than 100 metabolites were identified as significant between all stages; with the data analyzed, the average accuracies obtained in each of the five most-accurate implementations of genetic algorithms were in the range of 0.8214-0.9893 with respect to average accuracy, providing a precise tool to use in detections and backing up a diagnosis constructed entirely with metabolomics. By providing five potential biomarkers for progression, these extremely significant metabolites are as follows: "Cer(d18:1/24:1) i2", "PC(20:3-OH/P-18:1)", "Ganoderic acid C2", "TG(16:0/17:1/18:1)" and "GPEtn(18:0/20:4)".

Multimodal Early Alzheimer's Detection, a Genetic Algorithm Approach with Support Vector Machines.

Alzheimer's disease (AD) is a neurodegenerative disease that mainly affects older adults. Currently, AD is associated with certain hypometabolic biomarkers, beta-amyloid peptides, hyperphosphorylated tau protein, and changes in brain morphology. Accurate diagnosis of AD, as well as mild cognitive impairment (MCI) (prodromal stage of AD), is essential for early care of the disease. As a result, machine learning techniques have been used in recent years for the diagnosis of AD. In this research, we propose a novel methodology to generate a multivariate model that combines different types of features for the detection of AD. In order to obtain a robust biomarker, ADNI baseline data, clinical and neuropsychological assessments (1024 features) of 106 patients were used. The data were normalized, and a genetic algorithm was implemented for the selection of the most significant features. Subsequently, for the development and validation of the multivariate classification model, a support vector machine model was created, and a five-fold cross-validation with an AUC of 87.63% was used to measure model performance. Lastly, an independent blind test of our final model, using 20 patients not considered during the model construction, yielded an AUC of 100%.